Streetbeat News

Earnings

KOD

Kodiak Sciences (NASDAQ:KOD) reported a Q3 EPS loss of $(0.95), surpassing the consensus estimate of $(1.21) by 21.49%. This represents a 35.37% improvement from the $(1.47) per share loss in the same quarter last year.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 9:30 pm

ASXC

Asensus Surgical reported its Q3 2023 financial results, with an adjusted EPS of $(0.06), surpassing the $(0.07) estimate. However, the company's revenue of $1.1M fell short of the expected $1.987M estimate.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 9:30 pm

OMIC

Singular Genomics Systems (NASDAQ:OMIC) reported Q3 earnings with an EPS of $-0.31, beating estimates by 18.42% against an expected $-0.38. Revenue increased by $462 thousand compared to the same period last year. Despite beating EPS estimates last quarter, the share price fell by 3.0% the following day. The company's past earnings performance shows a pattern of surpassing EPS estimates but mixed results in revenue achievement.

Portfolio Pulse from Benzinga Insights

November 14, 2023 | 9:30 pm

BIAF

bioAffinity Technologies (NASDAQ:BIAF) reported a significant improvement in Q3 earnings with a loss of $(0.26) per share compared to a loss of $(1.10) per share in the same quarter last year. Sales also saw a dramatic increase to $298.48K from just $1.15K in the previous year's quarter.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 9:30 pm

AYTU

Aytu BioPharma (NASDAQ:AYTU) reported a larger Q1 loss of $(1.48) per share compared to $(1.20) per share in the same quarter last year. Sales for the quarter were $22.10M, which fell short of the analyst consensus estimate of $27.73M by 20.31%, and represented a 20.09% decrease from the $27.66M reported in the same period last year.

Portfolio Pulse from bharat@benzinga.com

November 14, 2023 | 9:30 pm

OTRK

Ontrak, Inc. has reaffirmed its financial outlook for the fiscal year 2023, maintaining its revenue estimate in the range of $12 million to $14 million. This projection is based on existing and planned enrollment launches, anticipated program expansions with current health plan partners, and current expectations with existing customers regarding outreach pool, budget considerations, and timing of expansions.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 9:28 pm

BFX

BowFlex reported its Q2 earnings with a narrower loss of $(0.35) per share compared to $(0.48) YoY, indicating an improvement in profitability. However, sales declined to $48.66M from $65.46M YoY, showing a decrease in revenue.

Portfolio Pulse from totan@benzinga.com

November 14, 2023 | 9:28 pm

OMIC

Singular Genomics Systems, trading as OMIC on NASDAQ, reported Q3 2023 earnings with a loss per share of $(0.31), outperforming the $(0.38) estimate. However, their sales of $462K fell short of the expected $1.27M, missing estimates by 63.62% and indicating a potential concern for revenue growth.

Portfolio Pulse from vinayak@benzinga.com

November 14, 2023 | 9:28 pm

PPSI

Pioneer Power Solutions forecasts its FY23 revenue to be between $42M-$45M, which is in line with the analyst estimate of $44.73M.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 9:28 pm

OTRK

Ontrak Inc. (OTRK) reported improved financial results for Q3 with a narrower loss of $(1.61) per share compared to $(2.88) per share in the same quarter last year. Sales also increased to $3.71M from $2.84M in the same period last year, marking a 30.67% growth.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 9:27 pm